series-b
Stage
1
Investors
About
Sangamo Therapeutics develops genomic medicine therapies using proprietary zinc finger technology to create genetic cures for severe diseases, focusing on neurological, oncological, and rare genetic conditions.
Explore Sangamo Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.